| Year |
Citation |
Score |
| 2023 |
Tardelli V, Xu KY, Bisaga A, Levin FR, Fidalgo TM, Grucza RA. Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk. Bmj Mental Health. 26. PMID 37500184 DOI: 10.1136/bmjment-2023-300728 |
0.309 |
|
| 2023 |
Greiner MG, Shulman M, Opara O, Potter K, Voronca DC, Tafessu HM, Hefner K, Hamilton A, Scheele C, Ho R, Dresser L, Jelstrom E, Fishman M, Ghitza UE, Rotrosen J, ... ... Bisaga A, et al. Surmounting withdrawal to initiate fast treatment with naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study. Contemporary Clinical Trials. 128: 107148. PMID 36931426 DOI: 10.1016/j.cct.2023.107148 |
0.352 |
|
| 2022 |
Williams AR, Aronowitz S, Gallagher R, Behar E, Gray Z, Bisaga A. A Virtual-First Telehealth Treatment Model for Opioid Use Disorder. Journal of General Internal Medicine. PMID 36456841 DOI: 10.1007/s11606-022-07955-x |
0.32 |
|
| 2022 |
Shulman M, Hu MC, Sullivan MA, Akerman SC, Fratantonio J, Barbieri V, Nunes EV, Bisaga A. Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials. Drug and Alcohol Dependence. 233: 109343. PMID 35131528 DOI: 10.1016/j.drugalcdep.2022.109343 |
0.383 |
|
| 2021 |
Levine A, Clemenza K, Weiss S, Bisaga A, Eitan E, Gerra MC, Donnini C, Gerra G, Garcia B. Discovering Non-Invasive Biomarkers Predictive of Opioid Use Disorder Treatment Response. Cns Spectrums. 26: 173. PMID 34127132 DOI: 10.1017/S1092852920002825 |
0.323 |
|
| 2021 |
Levin FR, Mariani JJ, Pavlicova M, Choi CJ, Basaraba C, Mahony AL, Brooks DJ, Naqvi N, Bisaga A. Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial. Drug and Alcohol Dependence. 219: 108482. PMID 33418204 DOI: 10.1016/j.drugalcdep.2020.108482 |
0.353 |
|
| 2020 |
Kidd JD, Smith JL, Hu MC, Turrigiano EM, Bisaga A, Nunes EV, Levin FR. Medical Student Attitudes Toward Substance Use Disorders Before and After a Skills-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) Curriculum. Advances in Medical Education and Practice. 11: 455-461. PMID 32636697 DOI: 10.2147/Amep.S251391 |
0.323 |
|
| 2020 |
Tardelli VS, Bisaga A, Arcadepani FB, Gerra G, Levin FR, Fidalgo TM. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis. Psychopharmacology. PMID 32601988 DOI: 10.1007/S00213-020-05563-3 |
0.413 |
|
| 2020 |
Nunes EV, Bisaga A, Krupitsky E, Nangia N, Silverman BL, Akerman SC, Sullivan MA. Reply to Kunoe (2020) and Ghosh and Singh (2020) regarding: Nunes et al., Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism. Addiction. 2020 Feb;115(2):239-246. Addiction (Abingdon, England). PMID 32533597 DOI: 10.1111/Add.15153 |
0.368 |
|
| 2020 |
Ghosh A, Roub F, Bisaga A. Drug treatment of SARS-Cov2: Potential effects in patients with substance use disorders (SUD). Journal of Psychosomatic Research. 135: 110159. PMID 32464504 DOI: 10.1016/J.Jpsychores.2020.110159 |
0.388 |
|
| 2019 |
Sibai M, Mishlen K, Nunes EV, Levin FR, Mariani JJ, Bisaga A. A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder. The American Journal of Drug and Alcohol Abuse. 1-8. PMID 31860366 DOI: 10.1080/00952990.2019.1700265 |
0.456 |
|
| 2019 |
Levin FR, Mariani JJ, Pavlicova M, Choi CJ, Mahony AL, Brooks DJ, Bisaga A, Dakwar E, Carpenter KM, Naqvi N, Nunes EV, Kampman K. Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users. Drug and Alcohol Dependence. 107700. PMID 31753736 DOI: 10.1016/J.Drugalcdep.2019.107700 |
0.38 |
|
| 2019 |
Nunes EV, Bisaga A, Krupitsky E, Nangia N, Silverman BL, Akerman SC, Sullivan MA. Opioid use and dropout from extended-release naltrexone in a controlled trial: Implications for mechanism. Addiction (Abingdon, England). PMID 31313402 DOI: 10.1111/Add.14735 |
0.45 |
|
| 2019 |
Williams AR, Nunes EV, Bisaga A, Levin FR, Olfson M. Development of a Cascade of Care for responding to the opioid epidemic. The American Journal of Drug and Alcohol Abuse. 1-10. PMID 30675818 DOI: 10.1080/00952990.2018.1546862 |
0.407 |
|
| 2019 |
Bisaga A. What should clinicians do as fentanyl replaces heroin? Addiction (Abingdon, England). PMID 30661265 DOI: 10.1111/Add.14522 |
0.355 |
|
| 2018 |
Sullivan MA, Bisaga A, Pavlicova M, Carpenter KM, Choi CJ, Mishlen K, Levin FR, Mariani JJ, Nunes EV. A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder. The American Journal of Psychiatry. appiajp201817070732. PMID 30336703 DOI: 10.1176/Appi.Ajp.2018.17070732 |
0.48 |
|
| 2018 |
Tardelli VS, Lago MPPD, Mendez M, Bisaga A, Fidalgo TM. Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review. Behaviour Research and Therapy. 111: 57-63. PMID 30316027 DOI: 10.1016/J.Brat.2018.10.002 |
0.348 |
|
| 2018 |
Jones JD, Bisaga A, Metz VE, Manubay JM, Mogali S, Ciccocioppo R, Madera G, Doernberg M, Comer SD. The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety. Journal of Psychoactive Drugs. 1-12. PMID 30204554 DOI: 10.1080/02791072.2018.1508789 |
0.362 |
|
| 2018 |
Williams AR, Nunes EV, Bisaga A, Pincus HA, Johnson KA, Campbell AN, Remien RH, Crystal S, Friedmann PD, Levin FR, Olfson M. Corrigendum to "Developing an opioid use disorder treatment cascade: A review of quality measures" [Journal of Substance Abuse Treatment 91 (2018) 57-68]. Journal of Substance Abuse Treatment. 92: 99. PMID 30032951 DOI: 10.1016/J.Jsat.2018.06.015 |
0.425 |
|
| 2018 |
Williams AR, Nunes EV, Bisaga A, Pincus HA, Johnson KA, Campbell AN, Remien RH, Crystal S, Friedmann PD, Levin FR, Olfson M. Developing an opioid use disorder treatment cascade: A review of quality measures. Journal of Substance Abuse Treatment. 91: 57-68. PMID 29910015 DOI: 10.1016/J.Jsat.2018.06.001 |
0.391 |
|
| 2018 |
Bisaga A, Mannelli P, Yu M, Nangia N, Graham CE, Tompkins DA, Kosten TR, Akerman SC, Silverman BL, Sullivan MA. Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial. Drug and Alcohol Dependence. 187: 171-178. PMID 29674251 DOI: 10.1016/J.Drugalcdep.2018.02.023 |
0.441 |
|
| 2018 |
Bisaga A, Mannelli P, Sullivan MA, Vosburg SK, Compton P, Woody GE, Kosten TR. Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies. The American Journal On Addictions. 27: 177-187. PMID 29596725 DOI: 10.1111/Ajad.12711 |
0.435 |
|
| 2017 |
Jones JD, Comer SD, Metz VE, Manubay JM, Mogali S, Ciccocioppo R, Martinez S, Mumtaz M, Bisaga A. Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential. Pharmacology, Biochemistry, and Behavior. PMID 29020601 DOI: 10.1016/J.Pbb.2017.10.002 |
0.33 |
|
| 2017 |
Williams AR, Barbieri V, Mishlen K, Levin FR, Nunes EV, Mariani JJ, Bisaga A. Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders. The American Journal On Addictions. PMID 28328148 DOI: 10.1111/Ajad.12527 |
0.381 |
|
| 2017 |
Sullivan M, Bisaga A, Pavlicova M, Choi CJ, Mishlen K, Carpenter KM, Levin FR, Dakwar E, Mariani JJ, Nunes EV. Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine. The American Journal of Psychiatry. appiajp201616050548. PMID 28068780 DOI: 10.1176/Appi.Ajp.2016.16050548 |
0.427 |
|
| 2017 |
Mishlen K, Barbieri VA, Sullivan MA, Bisaga A. Opioid use following an outpatient detoxification and induction onto XR-NTX: Testing the blockade as a predictor of retention in treatment Drug and Alcohol Dependence. 171: e146. DOI: 10.1016/J.Drugalcdep.2016.08.403 |
0.433 |
|
| 2016 |
Levin FR, Bisaga A, Sullivan MA, Williams AR, Cates-Wessel K. A review of a national training initiative to increase provider use of MAT to address the opioid epidemic. The American Journal On Addictions. 25: 603-609. PMID 28051841 DOI: 10.1111/Ajad.12454 |
0.372 |
|
| 2016 |
Williams AR, Bisaga A. From AIDS to Opioids - How to Combat an Epidemic. The New England Journal of Medicine. 375: 813-5. PMID 27579632 DOI: 10.1056/Nejmp1604223 |
0.378 |
|
| 2016 |
Bedi G, Shiffrin L, Vadhan NP, Nunes EV, Foltin RW, Bisaga A. Effects of levodopa-carbidopa-entacapone and smoked cocaine on facial affect recognition in cocaine smokers. Journal of Psychopharmacology (Oxford, England). PMID 26921145 DOI: 10.1177/0269881115626308 |
0.358 |
|
| 2015 |
Levin FR, Mariani JJ, Pavlicova M, Brooks D, Glass A, Mahony A, Nunes EV, Bisaga A, Dakwar E, Carpenter KM, Sullivan MA, Choi JC. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence. PMID 26711160 DOI: 10.1016/J.Drugalcdep.2015.11.025 |
0.368 |
|
| 2015 |
Bisaga A, Sullivan MA, Glass A, Mishlen K, Pavlicova M, Haney M, Raby WN, Levin FR, Carpenter KM, Mariani JJ, Nunes EV. The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone. Drug and Alcohol Dependence. PMID 26187456 DOI: 10.1016/J.Drugalcdep.2015.05.013 |
0.442 |
|
| 2015 |
Mogali S, Khan NA, Drill ES, Pavlicova M, Sullivan MA, Nunes E, Bisaga A. Baseline characteristics of patients predicting suitability for rapid naltrexone induction. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 24: 258-64. PMID 25907815 DOI: 10.1111/Ajad.12180 |
0.417 |
|
| 2015 |
Levin FR, Mariani JJ, Bisaga A, Nunes EV. Ling et al.'s 'Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder'. Addiction (Abingdon, England). 110: 875-6. PMID 25808040 DOI: 10.1111/Add.12885 |
0.41 |
|
| 2015 |
Sullivan MA, Bisaga A, Glass A, Mishlen K, Pavlicova M, Carpenter KM, Mariani JJ, Levin FR, Nunes EV. Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone. Drug and Alcohol Dependence. 147: 122-9. PMID 25555621 DOI: 10.1016/J.Drugalcdep.2014.11.028 |
0.367 |
|
| 2015 |
Vaughan B, Mariani JJ, Pavlicova M, Glass A, Bisaga A, Nunes EV, Brooks DJ, Levin FR. Secondary analysis of smoking rates from a double-blind, placebo-controlled clinical trial of mixed-amphetamine salts and topiramate for cocaine dependence Drug and Alcohol Dependence. 146: e10. DOI: 10.1016/J.Drugalcdep.2014.09.709 |
0.348 |
|
| 2014 |
Kelly MA, Pavlicova M, Glass A, Mariani JJ, Bisaga A, Sullivan MA, Nunes EV, Levin FR. Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR? Drug and Alcohol Dependence. 144: 42-6. PMID 25283697 DOI: 10.1016/J.Drugalcdep.2014.06.040 |
0.328 |
|
| 2014 |
Mariani JJ, Pavlicova M, Mamczur AK, Bisaga A, Nunes EV, Levin FR. Open-label pilot study of quetiapine treatment for cannabis dependence. The American Journal of Drug and Alcohol Abuse. 40: 280-4. PMID 24963729 DOI: 10.3109/00952990.2014.884102 |
0.38 |
|
| 2014 |
Bisaga A, Sullivan MA, Glass A, Mishlen K, Carpenter KM, Mariani JJ, Levin FR, Nunes EV. A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence. Journal of Substance Abuse Treatment. 46: 546-52. PMID 24560438 DOI: 10.1016/J.Jsat.2014.01.005 |
0.469 |
|
| 2014 |
Raby WN, Rubin EA, Garawi F, Cheng W, Mason E, Sanfilippo L, Lord S, Bisaga A, Aharonovich E, Levin F, McDowell D, Nunes EV. A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 23: 68-75. PMID 24313244 DOI: 10.1111/J.1521-0391.2013.12065.X |
0.384 |
|
| 2013 |
Hołuj M, Bisaga A, Popik P. Conditioned rewarding effects of morphine and methadone in mice pre-exposed to cocaine. Pharmacological Reports : Pr. 65: 1176-84. PMID 24399713 DOI: 10.1016/S1734-1140(13)71475-0 |
0.422 |
|
| 2013 |
Sullivan MA, Bisaga A, Mariani JJ, Glass A, Levin FR, Comer SD, Nunes EV. Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade? Drug and Alcohol Dependence. 133: 80-5. PMID 23827259 DOI: 10.1016/J.Drugalcdep.2013.05.030 |
0.455 |
|
| 2013 |
Levin FR, Mariani J, Brooks DJ, Pavlicova M, Nunes EV, Agosti V, Bisaga A, Sullivan MA, Carpenter KM. A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addiction (Abingdon, England). 108: 1084-94. PMID 23297841 DOI: 10.1111/Add.12108 |
0.317 |
|
| 2012 |
Mariani JJ, Pavlicova M, Bisaga A, Nunes EV, Brooks DJ, Levin FR. Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial. Biological Psychiatry. 72: 950-6. PMID 22795453 DOI: 10.1016/J.Biopsych.2012.05.032 |
0.381 |
|
| 2012 |
Sigmon SC, Bisaga A, Nunes EV, O'Connor PG, Kosten T, Woody G. Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice. The American Journal of Drug and Alcohol Abuse. 38: 187-99. PMID 22404717 DOI: 10.3109/00952990.2011.653426 |
0.443 |
|
| 2012 |
Horey JT, Mariani JJ, Cheng WY, Bisaga A, Sullivan M, Nunes E, Levin FR. Comparison of substance use milestones in cannabis- and cocaine-dependent patients. Journal of Addictive Diseases. 31: 60-6. PMID 22356669 DOI: 10.1080/10550887.2011.642753 |
0.362 |
|
| 2011 |
Dakwar E, Nunes EV, Bisaga A, Carpenter KC, Mariani JP, Sullivan MA, Raby WN, Levin FR. A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 20: 441-6. PMID 21838843 DOI: 10.1111/J.1521-0391.2011.00148.X |
0.332 |
|
| 2011 |
Bisaga A, Sullivan MA, Cheng WY, Carpenter KM, Mariani JJ, Levin FR, Raby WN, Nunes EV. A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence. Drug and Alcohol Dependence. 119: e23-9. PMID 21715107 DOI: 10.1016/J.Drugalcdep.2011.05.019 |
0.45 |
|
| 2011 |
Mariani JJ, Cheng WY, Bisaga A, Sullivan M, Carpenter K, Nunes EV, Levin FR. Comparison of clinical trial recruitment populations: treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participants. Journal of Substance Abuse Treatment. 40: 426-30. PMID 21439756 DOI: 10.1016/J.Jsat.2011.01.005 |
0.449 |
|
| 2011 |
Popik P, Kos T, Zhang Y, Bisaga A. Memantine reduces consumption of highly palatable food in a rat model of binge eating. Amino Acids. 40: 477-85. PMID 20571841 DOI: 10.1007/S00726-010-0659-3 |
0.32 |
|
| 2010 |
Brooks AC, Comer SD, Sullivan MA, Bisaga A, Carpenter KM, Raby WM, Yu E, O'Brien CP, Nunes EV. Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experiment. The Journal of Clinical Psychiatry. 71: 1371-8. PMID 20673549 DOI: 10.4088/Jcp.09M05080Ecr |
0.334 |
|
| 2010 |
Bisaga A, Aharonovich E, Cheng WY, Levin FR, Mariani JJ, Raby WN, Nunes EV. A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period. Drug and Alcohol Dependence. 111: 97-104. PMID 20537812 DOI: 10.1016/J.Drugalcdep.2010.04.006 |
0.413 |
|
| 2009 |
Raby WN, Carpenter KM, Rothenberg J, Brooks AC, Jiang H, Sullivan M, Bisaga A, Comer S, Nunes EV. Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 18: 301-8. PMID 19444734 DOI: 10.1080/10550490902927785 |
0.447 |
|
| 2009 |
Levin FR, Mariani JJ, Secora A, Brooks D, Cheng WY, Bisaga A, Nunes E, Aharonovich E, Raby W, Hennessy G. Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial. Journal of Dual Diagnosis. 5: 41-56. PMID 19430599 DOI: 10.1080/15504260802628767 |
0.355 |
|
| 2009 |
Carpenter KM, Jiang H, Sullivan MA, Bisaga A, Comer SD, Raby WN, Brooks AC, Nunes EV. Betting on change: modeling transitional probabilities to guide therapy development for opioid dependence. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 23: 47-55. PMID 19290689 DOI: 10.1037/A0013049 |
0.405 |
|
| 2008 |
Aharonovich E, Amrhein PC, Bisaga A, Nunes EV, Hasin DS. Cognition, commitment language, and behavioral change among cocaine-dependent patients. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 22: 557-62. PMID 19071981 DOI: 10.1037/A0012971 |
0.315 |
|
| 2008 |
Mariani JJ, Horey J, Bisaga A, Aharonovich E, Raby W, Cheng WY, Nunes E, Levin FR. Antisocial behavioral syndromes in cocaine and cannabis dependence. The American Journal of Drug and Alcohol Abuse. 34: 405-14. PMID 18584570 DOI: 10.1080/00952990802122473 |
0.353 |
|
| 2008 |
Akerele E, Bisaga A, Sullivan MA, Garawi F, Comer SD, Thomas AA, Nunes EV, Kleber HD. Dextromethorphan and quinidine combination for heroin detoxification. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 17: 176-80. PMID 18463993 DOI: 10.1080/10550490802019543 |
0.605 |
|
| 2008 |
Bisaga A, Kos T, Wójcikowski J, Daniel WA, Popik P. Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice. Drug and Alcohol Dependence. 95: 147-51. PMID 18328640 DOI: 10.1016/J.Drugalcdep.2008.01.007 |
0.399 |
|
| 2008 |
Levin FR, Bisaga A, Raby W, Aharonovich E, Rubin E, Mariani J, Brooks DJ, Garawi F, Nunes EV. Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence. Journal of Substance Abuse Treatment. 34: 80-9. PMID 17574796 DOI: 10.1016/J.Jsat.2006.11.012 |
0.376 |
|
| 2007 |
Sullivan MA, Garawi F, Bisaga A, Comer SD, Carpenter K, Raby WN, Anen SJ, Brooks AC, Jiang H, Akerele E, Nunes EV. Management of relapse in naltrexone maintenance for heroin dependence. Drug and Alcohol Dependence. 91: 289-92. PMID 17681716 DOI: 10.1016/J.Drugalcdep.2007.06.013 |
0.45 |
|
| 2007 |
Vorel SR, Bisaga A, McKhann G, Kleber HD. Insula damage and quitting smoking. Science (New York, N.Y.). 317: 318-9; author reply . PMID 17641181 DOI: 10.1126/Science.317.5836.318C |
0.473 |
|
| 2006 |
Aharonovich E, Garawi F, Bisaga A, Brooks D, Raby WN, Rubin E, Nunes EV, Levin FR. Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome. The American Journal of Drug and Alcohol Abuse. 32: 629-35. PMID 17127551 DOI: 10.1080/00952990600919005 |
0.407 |
|
| 2006 |
Levin FR, Brooks DJ, Bisaga A, Raby W, Rubin E, Aharonovich E, Nunes EV. Severity of dependence and motivation for treatment: comparison of marijuana- and cocaine-dependent treatment seekers. Journal of Addictive Diseases. 25: 33-41. PMID 16597571 DOI: 10.1300/J069V25N01_06 |
0.418 |
|
| 2006 |
Raby WN, Carpenter KM, Aharonovich E, Rubin E, Bisaga A, Levin F, Nunes EV. Temperament characteristics, as assessed by the tridimensional personality questionnaire, moderate the response to sertraline in depressed opiate-dependent methadone patients. Drug and Alcohol Dependence. 81: 283-92. PMID 16182468 DOI: 10.1016/J.Drugalcdep.2005.07.008 |
0.336 |
|
| 2006 |
Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug and Alcohol Dependence. 81: 313-22. PMID 16171953 DOI: 10.1016/J.Drugalcdep.2005.08.003 |
0.356 |
|
| 2006 |
Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, Nunes EV. A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug and Alcohol Dependence. 81: 267-74. PMID 16169160 DOI: 10.1016/J.Drugalcdep.2005.07.009 |
0.359 |
|
| 2006 |
Popik P, Wrobel M, Bisaga A. Reinstatement of morphine-conditioned reward is blocked by memantine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 160-70. PMID 15886718 DOI: 10.1038/Sj.Npp.1300760 |
0.421 |
|
| 2005 |
Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, Vosburg SK, Nunes EV. Utility of lead-in period in cocaine dependence pharmacotherapy trials. Drug and Alcohol Dependence. 77: 7-11. PMID 15607836 DOI: 10.1016/J.Drugalcdep.2004.06.007 |
0.385 |
|
| 2003 |
Popik P, Wrobel M, Rygula R, Bisaga A, Bespalov AY. Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice. Behavioural Pharmacology. 14: 237-44. PMID 12799526 DOI: 10.1097/00008877-200305000-00008 |
0.343 |
|
| 2003 |
Haney M, Bisaga A, Foltin RW. Interaction between naltrexone and oral THC in heavy marijuana smokers. Psychopharmacology. 166: 77-85. PMID 12491025 DOI: 10.1007/S00213-002-1279-8 |
0.387 |
|
| 2001 |
Bisaga A, Comer SD, Ward AS, Popik P, Kleber HD, Fischman MW. The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans. Psychopharmacology. 157: 1-10. PMID 11512037 DOI: 10.1007/S002130100739 |
0.61 |
|
| 2000 |
Bisaga A, Popik P, Bespalov AY, Danysz W. Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders. Expert Opinion On Investigational Drugs. 9: 2233-48. PMID 11060803 DOI: 10.1517/13543784.9.10.2233 |
0.362 |
|
| 2000 |
Bisaga A, Popik P. In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists. Drug and Alcohol Dependence. 59: 1-15. PMID 10706971 DOI: 10.1016/S0376-8716(99)00107-6 |
0.381 |
|
| 1997 |
Bisaga A, Gianelli P, Popik P. Opiate withdrawal with dextromethorphan. The American Journal of Psychiatry. 154: 584. PMID 9090360 |
0.323 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2023 |
Williams AR, Rowe C, Gallagher R, Aronowitz SV, Diamond-Reivich J, Bisaga A. Urine Drug Screening in a Telehealth Setting for the Treatment of Opioid Use Disorder. Jama Health Forum. 4: e232247. PMID 37505489 DOI: 10.1001/jamahealthforum.2023.2247 |
0.298 |
|
| 2023 |
Tardelli VS, Berro LF, Gerra G, Tadonio L, Bisaga A, Fidalgo TM. Prescription psychostimulants for cocaine use disorder: A review from molecular basis to clinical approach. Addiction Biology. 28: e13271. PMID 37016755 DOI: 10.1111/adb.13271 |
0.298 |
|
| 2023 |
Castillo F, Harris HM, Lerman D, Bisaga A, Nunes EV, Zhang Z, Wall M, Comer SD. Clinical Implications of the Relationship Between Naltrexone Plasma Levels and the Subjective Effects of Heroin in Humans. Journal of Addiction Medicine. PMID 38126709 DOI: 10.1097/ADM.0000000000001247 |
0.293 |
|
| 2008 |
Bisaga A, Danysz W, Foltin RW. Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 794-802. PMID 18573641 DOI: 10.1016/J.Euroneuro.2008.05.004 |
0.288 |
|
| 2004 |
Bisaga A, Evans SM. Acute effects of memantine in combination with alcohol in moderate drinkers. Psychopharmacology. 172: 16-24. PMID 14530901 DOI: 10.1007/S00213-003-1617-5 |
0.286 |
|
| 2007 |
Rubin E, Aharonovich E, Bisaga A, Levin FR, Raby WN, Nunes EV. Early abstinence in cocaine dependence: influence of comorbid major depression. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 16: 283-90. PMID 17661196 DOI: 10.1080/10550490701389880 |
0.285 |
|
| 2017 |
Barbieri VA, Mishlen K, Sullivan M, Bisaga A. Baseline predictors of outpatient induction onto extended-release naltrexone Drug and Alcohol Dependence. 171. DOI: 10.1016/J.Drugalcdep.2016.08.056 |
0.281 |
|
| 2007 |
Bisaga A, Padilla M, Garawi F, Sullivan MA, Haney M. Effects of alternative reinforcer and craving on the choice to smoke cigarettes in the laboratory. Human Psychopharmacology. 22: 41-7. PMID 17149785 DOI: 10.1002/Hup.816 |
0.28 |
|
| 2009 |
Evans SM, Bisaga A. Acute interaction of baclofen in combination with alcohol in heavy social drinkers. Alcoholism, Clinical and Experimental Research. 33: 19-30. PMID 18840257 DOI: 10.1111/J.1530-0277.2008.00805.X |
0.279 |
|
| 2017 |
Martinez S, Jones JD, Bisaga A, Comer SD. The effects of nicotine administration and drug cue on impulsivity Drug and Alcohol Dependence. 171: e130. DOI: 10.1016/J.Drugalcdep.2016.08.360 |
0.274 |
|
| 2022 |
Shulman M, Hu MC, Nunes EV, Bisaga A. Initiating Long-acting Injectable Naltrexone: Procedure for a Second Attempt After a First Attempt Fails. Journal of Addiction Medicine. PMID 35165228 DOI: 10.1097/ADM.0000000000000974 |
0.273 |
|
| 1993 |
Bisaga A, Krzascik P, Jankowska E, Palejko W, Kostowski W, Danysz W. Effect of glutamate receptor antagonists on N-methyl-D-aspartate- and (S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced convulsant effects in mice and rats. European Journal of Pharmacology. 242: 213-20. PMID 7506658 DOI: 10.1016/0014-2999(93)90244-C |
0.27 |
|
| 2021 |
Ghosh A, Bisaga A, Kaur S, Mahintamani T. Google Trends Data: A Potential New Tool for Monitoring the Opioid Crisis. European Addiction Research. 1-8. PMID 34265773 DOI: 10.1159/000517302 |
0.267 |
|
| 2020 |
Odusola F, Smith JL, Bisaga A, Grbic JT, Fine JB, Granger KE, Hu MC, Levin FR. Innovations in pre-doctoral dental education: Influencing attitudes and opinions about patients with substance use disorder. Journal of Dental Education. PMID 32022269 DOI: 10.1002/Jdd.12048 |
0.267 |
|
| 2013 |
Herron AJ, Mariani JJ, Pavlicova M, Parrinello CM, Bold KW, Levin FR, Nunes EV, Sullivan MA, Raby WN, Bisaga A. Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement. Drug and Alcohol Dependence. 128: 77-82. PMID 22921475 DOI: 10.1016/J.Drugalcdep.2012.08.007 |
0.263 |
|
| 2010 |
Comer SD, Cooper ZD, Kowalczyk WJ, Sullivan MA, Evans SM, Bisaga AM, Vosburg SK. Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal, healthy volunteers. Psychopharmacology. 208: 45-55. PMID 19859698 DOI: 10.1007/S00213-009-1703-4 |
0.262 |
|
| 2014 |
Mogali S, Khan NA, Drill ES, Pavlicova M, Sullivan MA, Nunes E, Bisaga A. Baseline characteristics of patients predicting suitability for rapid naltrexone induction. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 25556773 DOI: 10.1111/J.1521-0391.2014.12180.X |
0.262 |
|
| 2000 |
Radomska M, Bisaga A, Popik P. [Contemporary methods in pharmacotherapy in the opiate dependent treatment]. Przeglaì§D Lekarski. 57: 509-18. PMID 11199877 |
0.26 |
|
| 2023 |
Carpenter KM, Choi CJ, Basaraba C, Pavlicova M, Brooks DJ, Brezing CA, Bisaga A, Nunes EV, Mariani JJ, Levin FR. Mixed amphetamine salts-extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trial. Experimental and Clinical Psychopharmacology. PMID 37732961 DOI: 10.1037/pha0000676 |
0.256 |
|
| 1993 |
Bisaga A, Kostowski W. Individual behavioral differences and ethanol consumption in Wistar rats. Physiology & Behavior. 54: 1125-31. PMID 8295952 DOI: 10.1016/0031-9384(93)90336-E |
0.252 |
|
| 2008 |
Foltin RW, Danysz W, Bisaga A. A novel procedure for assessing the effects of drugs on satiation in baboons: effects of memantine and dexfenfluramine. Psychopharmacology. 199: 583-92. PMID 18481045 DOI: 10.1007/S00213-008-1178-8 |
0.252 |
|
| 2023 |
Williams AR, Aronowitz SV, Rowe C, Gallagher R, Behar E, Bisaga A. Telehealth for opioid use disorder: retention as a function of demographics and rurality. The American Journal of Drug and Alcohol Abuse. 1-6. PMID 36961998 DOI: 10.1080/00952990.2023.2180382 |
0.249 |
|
| 2006 |
Bisaga A, Evans SM. The acute effects of gabapentin in combination with alcohol in heavy drinkers. Drug and Alcohol Dependence. 83: 25-32. PMID 16298087 DOI: 10.1016/J.Drugalcdep.2005.10.008 |
0.247 |
|
| 2023 |
Shulman M, Greiner M, Bisaga A. Commentary on Foot et al.: Clinical considerations in addressing comorbid stimulant use in opioid use disorder. Addiction (Abingdon, England). PMID 37853655 DOI: 10.1111/add.16374 |
0.239 |
|
| 1998 |
Bisaga A, Katz JL, Antonini A, Wright CE, Margouleff C, Gorman JM, Eidelberg D. Cerebral glucose metabolism in women with panic disorder. The American Journal of Psychiatry. 155: 1178-83. PMID 9734539 DOI: 10.1176/Ajp.155.9.1178 |
0.239 |
|
| 2015 |
Vorel SR, Mahoney M, Bisaga A. Influence of nicotine replacement therapy on heart rate variability and relapse Drug and Alcohol Dependence. 146: e12-e13. DOI: 10.1016/J.Drugalcdep.2014.09.715 |
0.218 |
|
| 2005 |
Bisaga A, Laposata M, Xie S, Evans SM. Comparison of serum fatty acid ethyl esters and urinary 5-hydroxytryptophol as biochemical markers of recent ethanol consumption. Alcohol and Alcoholism (Oxford, Oxfordshire). 40: 214-8. PMID 15797884 DOI: 10.1093/Alcalc/Agh154 |
0.204 |
|
| 1991 |
Popik P, Vetulani J, Bisaga A, van Ree JM. Recognition cue in the rat's social memory paradigm. Journal of Basic and Clinical Physiology and Pharmacology. 2: 315-27. PMID 1822146 DOI: 10.1515/Jbcpp.1991.2.4.315 |
0.199 |
|
| 2021 |
Mariani JJ, Pavlicova M, Basaraba C, Mamczur-Fuller A, Brooks DJ, Bisaga A, Carpenter KM, Nunes E, Levin FR. Pilot randomized placebo-controlled clinical trial of high-dose gabapentin for alcohol use disorder. Alcoholism, Clinical and Experimental Research. PMID 34120336 DOI: 10.1111/acer.14648 |
0.188 |
|
| 2020 |
Mariani JJ, Pavlicova M, Jean Choi C, Basaraba C, Carpenter KM, Mahony AL, Brooks DJ, Bisaga A, Naqvi N, Nunes EV, Levin FR. Quetiapine treatment for cannabis use disorder. Drug and Alcohol Dependence. 108366. PMID 33153828 DOI: 10.1016/j.drugalcdep.2020.108366 |
0.186 |
|
| 2023 |
French R, Lyons E, Schachter A, Treston JA, Marshall A, Lattimer J, Bisaga A, Behar E, Aronowitz SV. "Because of this rotation, this is what I want to do": Implementation and evaluation of a telehealth opioid use disorder clinical placement for nurse practitioner students. Journal of the American Association of Nurse Practitioners. PMID 37756445 DOI: 10.1097/JXX.0000000000000949 |
0.167 |
|
| 2022 |
Tardelli VS, Bisaga A, Tadonio L, Gerra G, Fidalgo TM. Evidence-based Treatment for Stimulant Use Disorder: Time to Hit the Community. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437221148831. PMID 36583534 DOI: 10.1177/07067437221148831 |
0.163 |
|
| 2021 |
Odusola F, Smith JL, Turrigiano E, Shulman M, Grbic JT, Fine JB, Hu MC, Nunes EV, Bisaga A, Levin FR. The Utility of a Formative One-Station Objective Structured Clinical Examination for Substance Use Disorders in a Dental Curriculum. European Journal of Dental Education : Official Journal of the Association For Dental Education in Europe. PMID 33471403 DOI: 10.1111/eje.12661 |
0.16 |
|
| 1994 |
W?odarczyk-Bisaga K, Bisaga A. [Selected issues of biological aspects of eating disorders]. Psychiatria Polska. 28: 579-91. PMID 7991711 |
0.149 |
|
| 2021 |
Rodriguez-Moreno DV, Cycowicz YM, Figner B, Wang Z, He X, Geronazzo-Alman L, Sun X, Cheslack-Postava K, Bisaga A, Hoven CW, Amsel LV. Delay discounting and neurocognitive correlates among inner city adolescents with and without family history of substance use disorder. Developmental Cognitive Neuroscience. 48: 100942. PMID 33751954 DOI: 10.1016/j.dcn.2021.100942 |
0.138 |
|
| 1993 |
Bisaga A, Sikora J, Kostowski W. The effect of drugs interacting with serotonergic 5HT3 and 5HT4 receptors on morphine place conditioning. Polish Journal of Pharmacology. 45: 513-9. PMID 8012474 |
0.134 |
|
| 2020 |
Martinez S, Jones JD, Vadhan NP, Brandt L, Comer SD, Bisaga A. The acute and repeated effects of cigarette smoking and smoking-related cues on impulsivity. Drug and Alcohol Review. PMID 33140460 DOI: 10.1111/dar.13206 |
0.124 |
|
| 1994 |
Kostowski W, Bisaga A, Jankowska E, Krza?cik P. Studies on the effects of certain 5-HT-3 receptor antagonists on ethanol preference and withdrawal seizures in the rat. Polish Journal of Pharmacology. 46: 133-7. PMID 8000444 |
0.123 |
|
| 1995 |
Kostowski W, Sikora J, Bisaga A, Rosnowska E. Effects of 5-HT3 receptor antagonists on ethanol-induced hyperlocomotion in mice. Polish Journal of Pharmacology. 47: 293-7. PMID 8616507 |
0.12 |
|
| 2021 |
He X, Rodriguez-Moreno DV, Cycowicz YM, Cheslack-Postava K, Tang H, Wang Z, Amsel LV, Ryan M, Geronazzo-Alman L, Musa GJ, Bisaga A, Hoven CW. White matter integrity and functional connectivity in adolescents with a parental history of substance use disorder. Neuroimage. Reports. 1. PMID 36320407 DOI: 10.1016/j.ynirp.2021.100037 |
0.103 |
|
| 2022 |
Wang Z, Rodriguez-Moreno DV, Cycowicz YM, Amsel LV, Cheslack-Postava K, He X, Ryan M, Geronazzo-Alman L, Musa GJ, Bisaga A, Hoven CW. Shapes of subcortical structures in adolescents with and without familial history of substance use disorder. Human Brain Mapping. PMID 35393707 DOI: 10.1002/hbm.25804 |
0.093 |
|
| 1992 |
BISAGA A, KOSTOWSKI W, CAREY GJ, COSTALL B, DOMENEY AM. SOME BEHAVIORAL CORRELATES OF ETHANOL-SEEKING BEHAVIOR IN RATS CONDITIONED PLACE PREFERENCE IN THE COMMON MARMOSET (CALLITHRIX JACCHUS) Behavioural Pharmacology. 3: 61. DOI: 10.1097/00008877-199204001-00188 |
0.086 |
|
| 2010 |
Kowalczyk WJ, Sullivan MA, Evans SM, Bisaga AM, Vosburg SK, Comer SD. Sex differences and hormonal influences on response to mechanical pressure pain in humans. The Journal of Pain : Official Journal of the American Pain Society. 11: 330-42. PMID 19853526 DOI: 10.1016/J.Jpain.2009.08.004 |
0.064 |
|
| 1993 |
Bisaga A, Kostowski W. Selective breeding of rats differing in voluntary ethanol consumption. Polish Journal of Pharmacology. 45: 431-6. PMID 8118485 |
0.062 |
|
| 2006 |
Kowalczyk WJ, Evans SM, Bisaga AM, Sullivan MA, Comer SD. Sex differences and hormonal influences on response to cold pressor pain in humans. The Journal of Pain : Official Journal of the American Pain Society. 7: 151-60. PMID 16516820 DOI: 10.1016/J.Jpain.2005.10.004 |
0.053 |
|
| 2013 |
Williamson K, Bisaga A, Paquette K, Lovell E. The prevalence of methicillin-resistant Staphylococcus aureus colonization in emergency department fast track patients. World Journal of Emergency Medicine. 4: 278-9. PMID 25215132 DOI: 10.5847/wjem.j.1920-8642.2013.04.006 |
0.031 |
|
| 2022 |
Bisaga A, Tardelli VS, Gerra G, Busse A, Campello G, Kashino W, Saenz E, Fidalgo TM. Continuing . Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437221083505. PMID 35285278 DOI: 10.1177/07067437221083505 |
0.022 |
|
| 2008 |
Bisaga A, Paquette K, Sabatini L, Lovell EO. A prevalence study of methicillin-resistant Staphylococcus aureus colonization in emergency department health care workers. Annals of Emergency Medicine. 52: 525-8. PMID 18439725 DOI: 10.1016/j.annemergmed.2008.03.019 |
0.018 |
|
| Hide low-probability matches. |